Dr. Kraveka is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 Doughty Street, Suite 520
MSC 917
Charleston, SC 29403Phone+1 843-792-2957Fax+1 843-985-4256
Education & Training
- Medical University of South CarolinaFellowship, Pediatric Hematology/Oncology, 1997 - 2000
- Nicklaus Children's HospitalResidency, Pediatrics, 1994 - 1997
- Nova Southeastern University College of Osteopathic MedicineClass of 1994
Certifications & Licensure
- SC State License 1997 - 2025
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Exceptional Women in Medicine Castle Connolly, 2017-2024
- Top Doctors Castle Connolly, 2014-2024
- Top Hispanic and Latino Doctors Castle Connolly, 2023
- Join now to see all
Clinical Trials
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
- Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma Start of enrollment: 2003 Nov 01
- Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
- Join now to see all
Publications & Presentations
PubMed
- 63 citationsMaintenance DFMO Increases Survival in High Risk NeuroblastomaGiselle Saulnier Sholler, William S. Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, Kathleen A. Neville
Scientific Reports. 2018-09-27 - 75 citationsThe sphingosine kinase 2 inhibitor ABC294640 reduces the growth of prostate cancer cells and results in accumulation of dihydroceramides in vitro and in vivoHeather Venant, Mehrdad Rahmaniyan, E. Ellen Jones, Ping Lu, Michael B. Lilly
Molecular Cancer Therapeutics. 2015-12-01 - 6 citationsA Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma.Giselle Saulnier-Sholler, Dan G Duda, Genevieve Bergendahl, David Ebb, Matija Snuderl
Clinical Cancer Research. 2022-09-15
Press Mentions
- Make-a-Wish Grants 4,000th Wish at Event at MUSC Shawn Jenkins Children’s HospitalNovember 22nd, 2022
- Mayor Tecklenburg to Speak at MUSC Children’s Hospital for Childhood Cancer AwarenessSeptember 26th, 2016
- New Cancer Drug for Kid Tumors Tested at MUSC Enhances Survival and Quality of LifeDecember 21st, 2023
- Join now to see all
Grant Support
- Role Of Ceramide In Human Neuroblastoma DifferentiationNational Cancer Institute2003–2007
Professional Memberships
- Member
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: